Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

U. of Colorado researchers solve molecular structure involved with heart disease

17.04.2003


A group of researchers led by the University of Colorado at Boulder have solved the crystal structure of a molecule switch that can trigger heart disease and cancer, paving the way for future drug designs to mitigate these diseases.



The key component of the switch is a protein called MEF2 that binds to the DNA and is involved in muscle cell, T cell and nerve cell development. In cases involving human hearts, it can lower gene activity that causes enlarged hearts, known as hypertrophic cardiomyopathy, said Assistant Professor Lin Chen of CU-Boulder’s chemistry and biochemistry department who is leading the study.

MEF2 works in part by recruiting proteins known as histone deacetylases, or HDACs, that can modify DNA structure to suppress specific gene expression. MEF2 does so by either binding directly to HDACs or to an adaptor protein known as Cabin1 that in turn binds to HDACs.


Chen and his team recently determined the crystal structure of MEF2 that is bound to the molecule Cabin1 on DNA. Their studies revealed for the first time the detailed mechanisms by which MEF2 suppresses genes inside cells.

"The structure not only showed us how genes are properly silenced into a quiescent state by MEF2 and its associated molecules," said Chen, "but more importantly, it also suggested potential mechanisms by which MEF2 activates gene expression when cells are stimulated, especially when cells are inappropriately activated during hypertrophic responses in one’s heart."

A paper on the subject will be published in the April 17 issue of Nature. The first author is Aidong Han, a postdoctoral fellow in the Chen lab. Other authors include James Stroud, a CU graduate student in the Chen lab, and Fan Pan, Hong-Duk Youn and Jun O. Liu from Johns Hopkins University in Baltimore.

MEF2 and HDACs have drawn much attention because of their medical relevance, playing a key role in heart hypertrophy, which is often a response to other heart diseases and eventually turns into heart failure, said Chen. In the Western World, cardiovascular diseases account for about 43 percent of human deaths and for about 50 percent of all human hospitalizations.

The function of HDACs also is the focus of intensive medical research, said Chen. Scientists have shown that inhibitors of HDACs can halt the proliferation of tumor cells and cause them to die.

A number of HDAC inhibitors now are in clinical trials as anti-cancer drugs, he said, and there are continued efforts to search for more specific and less toxic blockers of HDACs. "The picture we have now by which HDACs are recruited to DNA will undoubtedly help this endeavor," he said.

"The structure reported by our lab is exciting because it suggests potential strategies for development of drugs to block the activity of HDACs and prevent MEF2 from activating genes in diseased cells," said Chen. "These drugs may help patients with heart disease and hopefully some cancers, benefiting human health enormously."


Contact:

Lin Chen, 303-735-0071, Lin.Chen@colorado.edu
Aidong Han, 303-492-2503, hanna@colorado.edu
Jim Scott, 303-492-3114

Lin Chen | EurekAlert!
Further information:
http://www.colorado.edu/

More articles from Life Sciences:

nachricht Colorectal cancer: Increased life expectancy thanks to individualised therapies
20.02.2020 | Christian-Albrechts-Universität zu Kiel

nachricht Sweet beaks: What Galapagos finches and marine bacteria have in common
20.02.2020 | Max-Planck-Institut für Marine Mikrobiologie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A step towards controlling spin-dependent petahertz electronics by material defects

The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.

Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

Active droplets

21.02.2020 | Medical Engineering

Finding new clues to brain cancer treatment

21.02.2020 | Health and Medicine

Beyond the brim, Sombrero Galaxy's halo suggests turbulent past

21.02.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>